Trispecific Antibody Emerges in Atopic Dermatitis Pipeline
HCPLive covers a novel trispecific molecule in development for moderate-to-severe atopic dermatitis — a three-pathway antibody designed to consolidate itch, IL-4/IL-13, and beyond into a single injec…